![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_63a607c7e7aae8221354f9a2188414df.svg) | Naltrexone | IC50 | 8.9 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_63a607c7e7aae8221354f9a2188414df.svg) | Naltrexone | Ki | 0.2 [1], 0.7 [2], 3.6 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_de181083409ad0c58f6501bc452ed426.svg) | Damgo | IC50 | 1.5 [1], 2.5 [2], 3.18 [3], 5.0 [4] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_de181083409ad0c58f6501bc452ed426.svg) | Damgo | Ki | 36.7 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_629c398a4b53125db843b1930cacf26a.svg) | Morphine | IC50 | 0.57 [1], 2.5 [2], 4.3 [3], 6.3 [4] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_629c398a4b53125db843b1930cacf26a.svg) | Morphine | Ki | 0.88 [1], 17.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_db4ac60c18b24b7bd003d4edf05f0d21.svg) | Naloxone | IC50 | 7.3 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_db4ac60c18b24b7bd003d4edf05f0d21.svg) | Naloxone | Ki | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5a2db8cf3e3e6db0222b04f0aecf810e.svg) | Norbinaltorphimine | IC50 | 212.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5a2db8cf3e3e6db0222b04f0aecf810e.svg) | Norbinaltorphimine | Ki | 21.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_6ec71103d3996924061aa2a8588c3702.svg) | Butorphan | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_6ec71103d3996924061aa2a8588c3702.svg) | Butorphan | Ki | 0.23 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_89d678ad823df51c3114498070bc797e.svg) | Naltrindole | Ki | 6.3 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_145248d95004a274bf2458fee2a3a138.svg) | Cyclorphan | IC50 | 1.7 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_145248d95004a274bf2458fee2a3a138.svg) | Cyclorphan | Ki | 0.06 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_84a1afe0c5c9b2843312065ae9097a12.svg) | n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide | IC50 | 248.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_01364df73df7620e09570711ec981302.svg) | Endomorphin-1 | IC50 | 3.2 [1], 14.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_012b530888547094791d0dfbbef9100c.svg) | (1S,2S,6R,14R,15S,16R)-5-(Cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol | IC50 | 1.7 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_27ecc918aa08958157c699d02d74843b.svg) | 3-(3,4-Dimethyl-1-phenethyl-piperidin-4-yl)-phenol | IC50 | 1.1 [1], 2.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_27ecc918aa08958157c699d02d74843b.svg) | 3-(3,4-Dimethyl-1-phenethyl-piperidin-4-yl)-phenol | Ki | 1.5 [1], 1.8 [2], 1.9 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1c2a2a423ad06aba56f3b6e9f2609218.svg) | Nalbuphine | IC50 | 1.0 [1], 110.0 [2], 752.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1c2a2a423ad06aba56f3b6e9f2609218.svg) | Nalbuphine | Ki | 0.89 [1], 1.6 [2], 9.93 [3], 14.31 [4] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_2049783460830b7ebd687fa8b3f84148.svg) | Levorphanol | IC50 | 0.13 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_2049783460830b7ebd687fa8b3f84148.svg) | Levorphanol | Ki | 0.21 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f841587dcc29b26fa84b16b2b6cfee8f.svg) | Dermorphin | IC50 | 0.72 [1], 1.82 [2], 2.4 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f841587dcc29b26fa84b16b2b6cfee8f.svg) | Dermorphin | Ki | 1.58 [1], 19.5 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_532b14a3aaab4a965b58ec37c062b0f2.svg) | Salvinorin A | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_55f4485a203a929dfb987e2c8b14d596.svg) | Clocinnamox | IC50 | 0.53 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_55f4485a203a929dfb987e2c8b14d596.svg) | Clocinnamox | Ki | 0.25 [1], 2.98 [2], 3.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_bf671c8a2966dab71244a37cb4e86000.svg) | MC-Cam | IC50 | 0.97 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_bf671c8a2966dab71244a37cb4e86000.svg) | MC-Cam | Ki | 0.46 [1], 4.78 [2], 4.8 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1df0d9eafb6dea8701f669d9e7cd2168.svg) | Bis[(1R,9R,10R)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-yl] decanedioate | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1df0d9eafb6dea8701f669d9e7cd2168.svg) | Bis[(1R,9R,10R)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-yl] decanedioate | Ki | 0.09 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_cc3d879534368dbf5806332e53cece48.svg) | Dpdpe | IC50 | 610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_cc3d879534368dbf5806332e53cece48.svg) | Dpdpe | Ki | 504.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_fb087281f8665e786637188efa2fac11.svg) | Nociceptin | Ki | 270.0 [1], 437.0 [2], 1000.0 [3], 3030.0 [4] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_0b773ae027050503bb83c9d874f68413.svg) | Diprenorphine | Ki | 0.07 [1], 0.12 [2], 0.2 [3], 0.27 [4], 0.33 [5] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_cdf3475992d12817672f77362f325376.svg) | Endomorphin 2 | Ki | 0.69 [1], 1.33 [2], 3.2 [3], 5.3 [4], 8.23 [5] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_104872a596c5ac0c5af81df7db78f1da.svg) | 4-(alpha-(4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide | IC50 | 320.0 [1], 4785.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_104872a596c5ac0c5af81df7db78f1da.svg) | 4-(alpha-(4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide | Ki | 352.0 [1], 1300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_a673b1de50a7f471380185d18f7e68cb.svg) | O-Desmethyltramadol | IC50 | 47.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_a673b1de50a7f471380185d18f7e68cb.svg) | O-Desmethyltramadol | Ki | 8.6 [1], 11.0 [2], 13.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1e190979702122d25bf0b74a60acd010.svg) | Bis[(1R,9R,10R)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-yl] (E)-but-2-enedioate | IC50 | 610.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1e190979702122d25bf0b74a60acd010.svg) | Bis[(1R,9R,10R)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-yl] (E)-but-2-enedioate | Ki | 0.2 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_18c83db0bf77c415399a84e9a6cef8a6.svg) | (1S,13R)-10-(Cyclopropylmethyl)-1,13-dimethyl-N-[2-(4-phenylphenyl)ethyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-4-carboxamide | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_18c83db0bf77c415399a84e9a6cef8a6.svg) | (1S,13R)-10-(Cyclopropylmethyl)-1,13-dimethyl-N-[2-(4-phenylphenyl)ethyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-4-carboxamide | Ki | 0.3 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_e5eec12d99c322e22f8e38fd7a14e6dd.svg) | 3-((2R,3R,7S,9As)-2,3-dimethyl-7-phenyl-octahydro-1H-quinolizin-2-yl)phenol | IC50 | 0.53 [1], 0.54 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_e5eec12d99c322e22f8e38fd7a14e6dd.svg) | 3-((2R,3R,7S,9As)-2,3-dimethyl-7-phenyl-octahydro-1H-quinolizin-2-yl)phenol | Ki | 0.62 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_a0bc71f61c7873b792ae4d9b4c4d8b0c.svg) | Leucine enkephalin | IC50 | 9500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_a0bc71f61c7873b792ae4d9b4c4d8b0c.svg) | Leucine enkephalin | Ki | 9.43 [1], 55.0 [2], 4800.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c45117ad154c21e4110d8ec236a71e57.svg) | Ultram | IC50 | 7600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c45117ad154c21e4110d8ec236a71e57.svg) | Ultram | Ki | 1600.0 [1], 2000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_d41c0420a7bf9dde258c17b932c5d2c1.svg) | Nalmefene | Ki | 0.24 [1], 0.44 [2], 0.91 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_03f8951aef77ea138df5d258fb4ba4fa.svg) | Alvimopan | IC50 | 1.7 [1], 3.16 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_03f8951aef77ea138df5d258fb4ba4fa.svg) | Alvimopan | Ki | 0.32 [1], 0.47 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_b8ad46a38eac2df3d29e8f0bec433803.svg) | 3-[(3R,4R)-1-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-3,4-dimethylpiperidin-4-yl]phenol | Ki | 0.04 [1], 0.1 [2], 0.15 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_b2ad6930002bf28dcef967ab5dbae658.svg) | 8-Carboxamidocyclazocine | IC50 | 5.6 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_b2ad6930002bf28dcef967ab5dbae658.svg) | 8-Carboxamidocyclazocine | Ki | 0.31 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_e96ee2fbd9c4a689d34f15b990dae676.svg) | N-[(4R,4As,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]pyridine-4-carboxamide | IC50 | 2.29 [1], 19.5 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_e96ee2fbd9c4a689d34f15b990dae676.svg) | N-[(4R,4As,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]pyridine-4-carboxamide | Ki | 0.37 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5f4a3a7aa47accaa8aae1c9839d798b9.svg) | N-[(4R,4As,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]isoquinoline-3-carboxamide | IC50 | 5.42 [1], 150.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5f4a3a7aa47accaa8aae1c9839d798b9.svg) | N-[(4R,4As,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]isoquinoline-3-carboxamide | Ki | 0.55 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_00c35499597e4e46e5713a74e69fe98b.svg) | (1R,12R,13R)-20-(Cyclopropylmethyl)-7-thia-5,20-diazapentacyclo[10.5.3.01,13.02,10.04,8]icosa-2,4(8),5,9-tetraen-6-amine | Ki | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_7f97807e67228eeb9a3769d68fbdfbf8.svg) | (1R,12R,13R)-20-(Cyclobutylmethyl)-7-thia-5,20-diazapentacyclo[10.5.3.01,13.02,10.04,8]icosa-2,4(8),5,9-tetraen-6-amine | IC50 | 85.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_7f97807e67228eeb9a3769d68fbdfbf8.svg) | (1R,12R,13R)-20-(Cyclobutylmethyl)-7-thia-5,20-diazapentacyclo[10.5.3.01,13.02,10.04,8]icosa-2,4(8),5,9-tetraen-6-amine | Ki | 7.1 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_7d820233f7e6b71189ea21f66c24d060.svg) | N,N-Diethyl-4-[phenyl-[(1S,5R)-8-(2-phenylethyl)-8-azabicyclo[3.2.1]octan-3-ylidene]methyl]benzamide | Ki | 72.0 [1], 72.3 [2], 317.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_98fa1906a1b55f60137b6734ffd9cdef.svg) | N,N-Dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine;hydrochloride | Ki | 0.26 [1], 0.6 [2], 310.0 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_df564f4be8b4c3b8ccfea559e33b06a9.svg) | N-[(1S)-1-[4-[[2-[2-[7-[[2-[2-[[(4R,4As,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethoxy]acetyl]amino]heptylamino]-2-oxoethoxy]acetyl]amino]phenyl]-3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]propyl]-4,4-difluorocyclohexane-1-carboxamide | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_df564f4be8b4c3b8ccfea559e33b06a9.svg) | N-[(1S)-1-[4-[[2-[2-[7-[[2-[2-[[(4R,4As,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethoxy]acetyl]amino]heptylamino]-2-oxoethoxy]acetyl]amino]phenyl]-3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]propyl]-4,4-difluorocyclohexane-1-carboxamide | Ki | 51.8 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f9614e97f6d0fb3b5152c962afb835e7.svg) | Fentanyl | IC50 | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f9614e97f6d0fb3b5152c962afb835e7.svg) | Fentanyl | Ki | 2.9 [1], 3.97 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c36e0c7e459d263b102bca66a36fc771.svg) | Codeine | IC50 | 105.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c36e0c7e459d263b102bca66a36fc771.svg) | Codeine | Ki | 727.0 [1], 6300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c17bcf953e2da4c9d97f36613ef408c8.svg) | Butorphanol | Ki | 0.12 [1], 0.22 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c1367d9ccaaa4f7766c7ca4c78d644a9.svg) | Levallorphan | Ki | 0.48 [1], 1.29 [2], 1.69 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_99514c14e56b2809c44d44d9beed7015.svg) | Naloxonazine | Ki | 1.45 [1], 2.92 [2], 3.16 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_fe6aeb199d5f77ddb6788fbccc3d36ee.svg) | 7-Benzylidenenaltrexone | Ki | 10.5 [1], 11.0 [2], 13.3 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_0cca5e159f895b6403a05303cf64f833.svg) | CompB | IC50 | 2200.0 [1], 3400.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_0cca5e159f895b6403a05303cf64f833.svg) | CompB | Ki | 400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9af8f6b81d67643b50fd16659c883036.svg) | Biphalin | IC50 | 1.4 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9af8f6b81d67643b50fd16659c883036.svg) | Biphalin | Ki | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5a8548a5c589fa30221e09bac06d3bcd.svg) | JTC-801 free base | IC50 | 1507.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_5a8548a5c589fa30221e09bac06d3bcd.svg) | JTC-801 free base | Ki | 102.0 [1], 102.9 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9589bea42af77ba72fdf0e68100a5be6.svg) | JDTic | Ki | 0.96 [1], 4.0 [2], 11.5 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_fd6e969b835183c769a2eb12d97b8c9b.svg) | Herkinorin | Ki | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9d2dd6cb955ef516440b2ad33a2af82d.svg) | Leu-enkephalinamide | IC50 | 26.1 [1], 57.8 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9d2dd6cb955ef516440b2ad33a2af82d.svg) | Leu-enkephalinamide | Ki | 11.4 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_1b4c8e65035e1556c7e7a62d9d2e7ba3.svg) | Salvinorin B | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c87cf4f68c06491c83a66c1e07826eb7.svg) | 4-[[(4-Methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_c87cf4f68c06491c83a66c1e07826eb7.svg) | 4-[[(4-Methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | Ki | 306.0 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f0bd82bce8022fb002307428ad940433.svg) | 3-Desoxy-3-carboxamidonaltrexone | Ki | 0.71 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_43466e21ddfcf4309f51394c801e5f87.svg) | (4R,7S,10S,13R,16S,19R)-N-[(2S,3R)-1-Amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-10-[3-(diaminomethylideneamino)propyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Ki | 1.06 [1], 2.33 [2], 2.96 [3] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_46564fcd62df1bc7dd543d99cd50f162.svg) | (1R,9R,10R)-17-(Cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-amine | Ki | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f6dfdabb90d41aaced67da8a13ecaa2d.svg) | (1R,9R,10R)-17-(Cyclopropylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-amine | Ki | 1.3 [1] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_9d7129ea73823364de5b0b0914c18254.svg) | (4As,9aR)-4a-ethyl-2-(2-phenylethyl)-1,3,4,9a-tetrahydro-[1]benzofuro[2,3-c]pyridin-6-ol | Ki | 0.7 [1], 0.9 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_85ff6531272f39c45c35b5bf74b602b9.svg) | 1-Benzhydryl-4-phenylpiperidin-4-ol | Ki | 207.0 [1], 233.0 [2] |
![](https://images.aatbio.com/dataset/ic50/mu-opioid-receptor_f7194de042f91d92b872cf66ab6187ba.svg) | (3R)-3-Methyl-4-[5-chloro-2-(tert-butylthio)-1H-benzoimidazole-6-yl]-1-piperazineethanol | IC50 | 97.0 [1], 1900.0 [2] |